Kimberly Pope
Human Resources Officer chez ADC THERAPEUTICS SA
Fortune : 935 824 $ au 31/03/2024
Profil
Kimberly Pope is currently the Chief People Officer at ADC Therapeutics SA. Prior to this, she held positions as the Director of Human Resources at Hospira, Inc. and Global Marketing & Development Solutions.
She also served as the Group Vice President of Human Resources at IDEX Corp.
from 2013 to 2016.
From 2016 to 2020, she was the Senior Vice President of Human Resources at Array BioPharma, Inc. Ms. Pope obtained her undergraduate degree from the University of Iowa and also studied at the Tippie College of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,25% | 01/02/2023 | 208 424 ( 0,25% ) | 935 824 $ | 31/03/2024 |
Postes actifs de Kimberly Pope
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Human Resources Officer | 17/08/2020 |
Anciens postes connus de Kimberly Pope
| Sociétés | Poste | Fin |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Human Resources Officer | 01/01/2019 |
| IDEX CORPORATION | Human Resources Officer | 01/01/2016 |
| Global Marketing & Development Solutions | Human Resources Officer | - |
| HOSPIRA, INC. | Human Resources Officer | - |
Formation de Kimberly Pope
| University of Iowa | Undergraduate Degree |
| Tippie College of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IDEX CORPORATION | Producer Manufacturing |
| ADC THERAPEUTICS SA | Health Technology |
| Entreprise privées | 3 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
| Global Marketing & Development Solutions |
